Research.Patient.info
Leukemia, Myeloid, Acute research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE1
A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
This study is testing a new drug, JNJ-89853413, for people in the UK with certain types of blood cancer (relapsed or refractory AML or MDS) that haven't responded well to previous treatments. It aims to find a safe dose and see how well it works.
Canada · Spain · United Kingdom - recruitingPHASE1
A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
This study is testing a new drug, JNJ-90189892, sometimes with other medicines, for adults with acute myeloid leukemia (AML) or certain types of myelodysplastic neoplasms (MDS). It aims to find the safest and most effective doses for these blood cancers.
Australia · France · Spain